Bidimensional Measurements of Right Ventricular Function for Prediction of Survival in Patients with Pulmonary Hypertension: Comparison of Reproducibility and Time of Analysis with Volumetric Cardiac Magnetic Resonance Imaging Analysis

We tested the hypothesis that bidimensional measurements of right ventricular (RV) function obtained by cardiac magnetic resonance imaging (CMR) in patients with pulmonary arterial hypertension (PAH) are faster than volumetric measures and highly reproducible, with comparable ability to predict patient survival. CMR-derived tricuspid annular plane systolic excursion (TAPSE), RV fractional shortening (RVFS), RV fractional area change (RVFAC), standard functional and volumetric measures, and ventricular mass index (VMI) were compared with right heart catheterization data. CMR analysis time was recorded. Receiver operating characteristic curves, Kaplan-Meier, Cox proportional hazard (CPH), and Bland-Altman test were used for analysis. Forty-nine subjects with PAH and 18 control subjects were included. TAPSE, RVFS, RVFAC, RV ejection fraction, and VMI correlated significantly with pulmonary vascular resistance and mean pulmonary artery pressure (all P < 0.05). Patients were followed up for a mean (± standard deviation) of 2.5 ± 1.6 years. Kaplan-Meier curves showed that death was strongly associated with TAPSE <18 mm, RVFS <16.7%, and RVFAC <18.8%. In CPH models with TAPSE as dichotomized at 18 mm, TAPSE was significantly associated with risk of death in both unadjusted and adjusted models (hazard ratio, 4.8; 95% confidence interval, 2.0–11.3; P = 0.005 for TAPSE <18 mm). There was high intra- and interobserver agreement. Bidimensional measurements were faster (1.5 ± 0.3 min) than volumetric measures (25 ± 6 min). In conclusion, TAPSE, RVFS, and RVFAC measures are efficient measures of RV function by CMR that demonstrate significant correlation with invasive measures of PAH severity. In patients with PAH, TAPSE, RVFS, and RVFAC have high intra- and interobserver reproducibility and are more rapidly obtained than volumetric measures. TAPSE <18 mm by CMR was strongly and independently associated with survival in PAH.

[1]  R. Nijveldt,et al.  Semi-quantitative assessment of right ventricular function in comparison to a 3D volumetric approach: A cardiovascular magnetic resonance study , 2008, European Radiology.

[2]  J. Foster,et al.  Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure , 2002, European Respiratory Journal.

[3]  S. Plein,et al.  Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady‐state free precession imaging sequences , 2003, Journal of magnetic resonance imaging : JMRI.

[4]  S. Ghio,et al.  Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension. , 2010, International journal of cardiology.

[5]  Mario J. Garcia,et al.  RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness. , 2012, JACC. Cardiovascular imaging.

[6]  Jim M Wild,et al.  Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry , 2012, Journal of Cardiovascular Magnetic Resonance.

[7]  D. Bluemke,et al.  Right and left ventricular myocardial perfusion reserves correlate with right ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension. , 2011, Radiology.

[8]  S. Hunt,et al.  Right Ventricular Function in Cardiovascular Disease, Part I: Anatomy, Physiology, Aging, and Functional Assessment of the Right Ventricle , 2008, Circulation.

[9]  J. Krishnan,et al.  Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. , 2006, Arthritis and rheumatism.

[10]  S. Kaul,et al.  Assessment of right ventricular function using two-dimensional echocardiography. , 1984, American heart journal.

[11]  M. Szklo,et al.  Epidemiology: Beyond the Basics , 1999 .

[12]  J. Wild,et al.  Comparison of the Diagnostic Utility of Cardiac Magnetic Resonance Imaging, Computed Tomography, and Echocardiography in Assessment of Suspected Pulmonary Arterial Hypertension in Patients with Connective Tissue Disease , 2012, The Journal of Rheumatology.

[13]  Kohtaro Abe,et al.  The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. , 2009, Chest.

[14]  James O. Mudd,et al.  Tricuspid Annular Plane Systolic Excursion Is a Robust Outcome Measure in Systemic Sclerosis-associated Pulmonary Arterial Hypertension , 2011, The Journal of Rheumatology.

[15]  N. Westerhof,et al.  Progressive changes in right ventricular geometric shortening and long-term survival in pulmonary arterial hypertension. , 2012, Chest.

[16]  J. Bronzwaer,et al.  Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. , 2007, European heart journal.

[17]  James O. Mudd,et al.  Pulmonary arterial hypertension: MR imaging-derived first-pass bolus kinetic parameters are biomarkers for pulmonary hemodynamics, cardiac function, and ventricular remodeling. , 2012, Radiology.

[18]  J. Wild,et al.  Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension. , 2009, Rheumatology.

[19]  A. Zaiman,et al.  Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension. , 2010, American journal of respiratory and critical care medicine.

[20]  Richard D. White,et al.  Cardiovascular magnetic resonance for the assessment of pulmonary arterial hypertension: toward a comprehensive CMR exam. , 2012, Magnetic resonance imaging.

[21]  J. McGhie,et al.  Right ventricular quantification in clinical practice: two-dimensional vs. three-dimensional echocardiography compared with cardiac magnetic resonance imaging. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[22]  James C Moon,et al.  Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. , 2004, American heart journal.

[23]  T. Abraham,et al.  Tricuspid annular displacement predicts survival in pulmonary hypertension. , 2006, American journal of respiratory and critical care medicine.

[24]  J. Oh,et al.  Evaluation of right ventricular volume and function by 2D and 3D echocardiography compared to MRI. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[25]  David A Bluemke,et al.  Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling. , 2011, AJR. American journal of roentgenology.

[26]  D. Bluemke,et al.  Regional and global biventricular function in pulmonary arterial hypertension: a cardiac MR imaging study. , 2013, Radiology.

[27]  B. Sievers,et al.  Tricuspid annular plane systolic excursion assessed using MRI for semi-quantification of right ventricular ejection fraction. , 2012, The British journal of radiology.

[28]  K R Hess,et al.  Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. , 1995, Statistics in medicine.

[29]  Caroline Petitjean,et al.  Diagnostic accuracy and variability of three semi-quantitative methods for assessing right ventricular systolic function from cardiac MRI in patients with acquired heart disease , 2011, European Radiology.

[30]  Nico Westerhof,et al.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. , 2011, Journal of the American College of Cardiology.